Greenwich LifeSciences (GLSI) Shares Outstanding (2019 - 2025)

Greenwich LifeSciences filings provide 7 years of Shares Outstanding readings, the most recent being $13.8 million for Q3 2025.

  • Quarterly Shares Outstanding rose 4.94% to $13.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Sep 2025, up 4.94% year-over-year, with the annual reading at $13.2 million for FY2024, 2.37% up from the prior year.
  • Shares Outstanding hit $13.8 million in Q3 2025 for Greenwich LifeSciences, up from $13.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $13.8 million in Q3 2025 and bottomed at $12.8 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $13.0 million, with a median of $12.9 million recorded in 2021.
  • The largest annual shift saw Shares Outstanding skyrocketed 552.42% in 2021 before it fell 2.28% in 2022.
  • Greenwich LifeSciences' Shares Outstanding stood at $13.1 million in 2021, then dropped by 2.28% to $12.8 million in 2022, then changed by 0.0% to $12.8 million in 2023, then rose by 2.37% to $13.2 million in 2024, then grew by 4.88% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Shares Outstanding are $13.8 million (Q3 2025), $13.5 million (Q2 2025), and $13.2 million (Q1 2025).